Overview

Lyrica Dose Response Study With Restless Legs Syndrome (RLS) Patients

Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
To test the effectiveness and tolerability of Lyrica at various dose levels in RLS patients
Phase:
Phase 2
Details
Lead Sponsor:
Pfizer
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Treatments:
Pregabalin